$3M NIH Grant Supports Genomic Approach to Curing "Neglected" Disease

Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers

Media Type
Article
Publish or Event Date
Research Institution
Innovation Pharmaceuticals
Short Title
Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers
Content Coordinator
Content Manager

Engineering a Malaria Vaccine

Study Seeks to Identify Prenatal Allergy Risk Markers

Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic

Media Type
Article
Publish or Event Date
Research Institution
University of California San Diego School of Medicine
Short Title
Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic
Content Coordinator
Content Manager

Tulane University Awarded up to $16 Million to Bring Pneumonia Nasal Vaccine to Clinical Trials

Media Type
Article
Publish or Event Date
Research Institution
Tulane University
Short Title
Tulane University Awarded up to $16 Million to Bring Pneumonia Nasal Vaccine to Clinical Trials
Content Coordinator
Content Manager

E. coli Uses Serine to Abide Acidity

NIH, NSF Fund UAMS Study of Rapid Genomic Testing to Aid Treatment of Dangerous Antibiotic-Resistant Infections

Media Type
Article
Publish or Event Date
Research Institution
University of Arkansas for Medical Sciences
Short Title
NIH, NSF Fund UAMS Study of Rapid Genomic Testing to Aid Treatment of Dangerous Antibiotic-Resistant Infections
Content Coordinator
Content Manager

Wiebe Expands Study of Poxviruses, Immune Function

We’ve Learned a lot from Lymphocytic Choriomeningitis Virus—Now the Time has Come to Fight It

Media Type
Article
Publish or Event Date
Research Institution
La Jolla Institute for Immunology
Short Title
We’ve Learned a lot from Lymphocytic Choriomeningitis Virus—Now the Time has Come to Fight It
Content Coordinator
Content Manager